NCT00422877 2025-10-16
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
American Regent, Inc.
Phase 2 Terminated
American Regent, Inc.
S.L.A. Pharma AG
Royal Surrey County Hospital NHS Foundation Trust
Mayo Clinic
The First Hospital of Jilin University
University of Leeds